Addendum: Polyclonal on- and off-target resistance mutations in an EML4-ALK positive non-small cell lung cancer patient under ALK inhibition.

Kemper, Marcel; Evers, Georg; Schulze, Arik Bernard; Sperveslage, Jan; Schülke, Christoph; Lenz, Georg; Herold, Thomas; Hartmann, Wolfgang; Schildhaus, Hans-Ulrich; Bleckmann, Annalen

Kemper, Marcel; Evers, Georg; Schulze, Arik Bernard; Sperveslage, Jan; Schülke, Christoph; Lenz, Georg; Herold, Thomas; Hartmann, Wolfgang; Schildhaus, Hans-Ulrich; Bleckmann, Annalen.

Afiliación

Kemper M; Department of Medicine A, Hematology, Oncology, and Pneumology, University Hospital Muenster, 48149 Muenster, Germany.
Evers G; West German Cancer Center, Sites Muenster & Essen, 45147 Essen, Germany.
Schulze AB; Authors share first authorship.
Sperveslage J; Department of Medicine A, Hematology, Oncology, and Pneumology, University Hospital Muenster, 48149 Muenster, Germany.
Schülke C; West German Cancer Center, Sites Muenster & Essen, 45147 Essen, Germany.
Lenz G; Authors share first authorship.
Herold T; Department of Medicine A, Hematology, Oncology, and Pneumology, University Hospital Muenster, 48149 Muenster, Germany.
Hartmann W; West German Cancer Center, Sites Muenster & Essen, 45147 Essen, Germany.
Schildhaus HU; Gerhard-Domagk-Institute of Pathology, University Hospital Muenster, 48149 Muenster, Germany.
Bleckmann A; Institute of Clinical Radiology, University Hospital Muenster, 48149 Muenster, Germany.

Oncotarget ; 13: 1216, 2022 Nov 02.

Article en En | MEDLINE | ID: mdl-36342457

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Oncotarget Año: 2022 Tipo del documento: Article País de afiliación: Alemania

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google